The Pennant Group, Inc. (NASDAQ:PNTG) Stock Now Rated “Moderate Buy” by Sell-Side Brokerages

The Pennant Group, Inc. (NASDAQ:PNTG) has received a consensus recommendation of “Moderate Buy” from the seven brokerages that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $42.00.

A number of equities analysts have recently commented on the company. Weiss Ratings raised The Pennant Group from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, August 19th. Truist Financial increased their target price on shares of The Pennant Group from $42.00 to $48.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Royal Bank Of Canada increased their target price on shares of The Pennant Group from $42.00 to $44.00 and gave the stock an “outperform” rating in a report on Thursday, August 20th. Wells Fargo & Company raised their price target on shares of The Pennant Group from $45.00 to $46.00 and gave the company an “overweight” rating in a research note on Tuesday, August 11th. Finally, Wall Street Zen raised shares of The Pennant Group from a “hold” rating to a “buy” rating in a report on Saturday, June 20th.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Nykredit A S acquired a new position in The Pennant Group in the 2nd quarter valued at approximately $29,000. Caitong International Asset Management Co. Ltd raised its position in The Pennant Group by 154.2% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,182 shares of the company’s stock worth $33,000 after purchasing an additional 717 shares during the last quarter. Parallel Advisors LLC raised its position in The Pennant Group by 1,186.8% during the 1st quarter. Parallel Advisors LLC now owns 1,364 shares of the company’s stock worth $42,000 after purchasing an additional 1,258 shares during the last quarter. GAMMA Investing LLC raised its position in The Pennant Group by 34.6% during the 2nd quarter. GAMMA Investing LLC now owns 1,568 shares of the company’s stock worth $58,000 after purchasing an additional 403 shares during the last quarter. Finally, Fifth Third Bancorp lifted its holdings in The Pennant Group by 548.9% during the 1st quarter. Fifth Third Bancorp now owns 6,807 shares of the company’s stock worth $207,000 after buying an additional 5,758 shares during the period. 85.88% of the stock is currently owned by institutional investors and hedge funds.

The Pennant Group Trading Up 1.7%

Shares of PNTG stock opened at $40.82 on Thursday. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.48. The stock has a market cap of $1.43 billion, a P/E ratio of 45.36, a price-to-earnings-growth ratio of 2.62 and a beta of 1.25. The stock has a 50 day simple moving average of $39.26 and a 200 day simple moving average of $36.33. The Pennant Group has a 1 year low of $22.25 and a 1 year high of $42.74.

The Pennant Group (NASDAQ:PNTG) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.03. The business had revenue of $297.98 million for the quarter, compared to the consensus estimate of $288.71 million. The Pennant Group had a return on equity of 10.33% and a net margin of 2.93%. The Pennant Group has set its FY 2026 guidance at 1.340-1.410 EPS. On average, research analysts predict that The Pennant Group will post 1.18 earnings per share for the current fiscal year.

The Pennant Group Company Profile

The Pennant Group, Inc (NASDAQ:PNTG) is a healthcare services company that operates businesses focused on home-based care and senior living. Through its affiliated companies, Pennant provides home health, hospice and personal care services, as well as residential senior living services for older adults with varying care needs.

Its home health operations offer clinical care and rehabilitation services in patients’ homes, while its hospice businesses provide comfort-focused care and support for individuals with advanced illnesses and their families.